Hester Biosciences Ltd vs Sakar Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Hester Biosciences Ltd is ₹ 1664 as of 04 May 10:18 . The P/E Ratio of Hester Biosciences Ltd changed from 47.4 on March 2021 to 38.8 on March 2025 . This represents a CAGR of -3.92% over 5 yearsThe P/E Ratio of Sakar Healthcare Ltd changed from 16.5 on March 2021 to 26.6 on March 2025 . This represents a CAGR of 10.02% over 5 years The Market Cap of Hester Biosciences Ltd changed from ₹ 1630 crore on March 2021 to ₹ 1066 crore on March 2025 . This represents a CAGR of -8.14% over 5 yearsThe Market Cap of Sakar Healthcare Ltd changed from ₹ 176.64 crore on March 2021 to ₹ 464.72 crore on March 2025 . This represents a CAGR of 21.34% over 5 years The revenue of Hester Biosciences Ltd for the Dec '25 is ₹ 79.4 crore as compare to the Sep '25 revenue of ₹ 82.85 crore. This represent the decline of -4.16% The revenue of Sakar Healthcare Ltd for the Dec '25 is ₹ 70.85 crore as compare to the Sep '25 revenue of ₹ 58.78 crore. This represent the growth of 20.53% The ebitda of Hester Biosciences Ltd for the Dec '25 is ₹ 19.78 crore as compare to the Sep '25 ebitda of ₹ 23.6 crore. This represent the decline of -16.19% The ebitda of Sakar Healthcare Ltd for the Dec '25 is ₹ 19.1 crore as compare to the Sep '25 ebitda of ₹ 12.57 crore. This represent the growth of 51.95% The net profit of Hester Biosciences Ltd changed from ₹ 7.49 crore to ₹ 9.31 crore over 7 quarters. This represents a CAGR of 13.24% The net profit of Sakar Healthcare Ltd changed from ₹ 2.41 crore to ₹ 10.25 crore over 7 quarters. This represents a CAGR of 128.70% The Dividend Payout of Hester Biosciences Ltd changed from 21.33 % on March 2021 to 18.71 % on March 2025 . This represents a CAGR of -2.59% over 5 yearsThe Dividend Payout of Sakar Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Hester Biosciences Ltd

Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India.
The Company was incorporated in April, 1987 and is engaged in manufacturing of Poultry vaccines and Large Animal Vaccines and trading of Poultry and Large animal and Petcare health products having its manufacturing set up at Meda Adraj Village, Mehsana District, Gujarat. The Company built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh.
The products and services included over 51 vaccines and 70+ health products.
In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals. The Company markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents.

About Sakar Healthcare Ltd

Sakar Healthcare Limited was incorporated as a Private Limited Company under the name 'Sakar Healthcare Private Limited on 26th March 2004.
Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to 'Sakar Healthcare Limited.
The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah. The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages.
It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

FAQs for the comparison of Hester Biosciences Ltd and Sakar Healthcare Ltd

Which company has a larger market capitalization, Hester Biosciences Ltd or Sakar Healthcare Ltd?

Market cap of Hester Biosciences Ltd is 1,393 Cr while Market cap of Sakar Healthcare Ltd is 1,397 Cr

What are the key factors driving the stock performance of Hester Biosciences Ltd and Sakar Healthcare Ltd?

The stock performance of Hester Biosciences Ltd and Sakar Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hester Biosciences Ltd and Sakar Healthcare Ltd?

As of May 4, 2026, the Hester Biosciences Ltd stock price is INR ₹1638.3. On the other hand, Sakar Healthcare Ltd stock price is INR ₹628.05.

How do dividend payouts of Hester Biosciences Ltd and Sakar Healthcare Ltd compare?

To compare the dividend payouts of Hester Biosciences Ltd and Sakar Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.